Cartilage Oligomeric Matrix Protein Increases in Photodamaged Skin. 2016

Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
Biological Science Research, Kao Corporation, Odawara, Kanagawa, Japan; Department of Plastic Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan. Electronic address: kobayashi.masaki2@kao.co.jp.

Cartilage oligomeric matrix protein (COMP) is a structural component of cartilage. Recent studies have described COMP as a pathogenic factor that promotes collagen deposition in fibrotic skin disorders such as scleroderma and keloid skin. Although collagen, a major dermis component, is thought to decrease in photoaged skin, recent reports have demonstrated the presence of tightly packed collagen fibrils with a structural resemblance to fibrosis in the papillary dermis of photoaged skin. Here we examined how photoaging damage relates to COMP expression and localization in photoaged skin. In situ hybridization revealed an increase in COMP-mRNA-positive cells with the progress of photoaging in preauricular skin (sun-exposed skin). The signal intensity of immunostaining for COMP increased with photoaging in not only the papillary dermis but also the reticular dermis affected by advancing solar elastosis. Immunoelectron microscopy detected the colocalization of COMP with both elastotic materials and collagen fibrils in photoaged skin. Ultraviolet light A irradiation of human dermal fibroblasts induced COMP expression at both the mRNA and protein levels. Ultraviolet light A-induced COMP expression was inhibited by an anti-transforming growth factor-β antibody or SB431542, an activin receptor-like kinase 5 inhibitor. These results suggest that the transforming growth factor-β-mediated upregulation of COMP expression may contribute to the modulation of dermal extracellular matrix in the photoaging process.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
December 2007, Rheumatology (Oxford, England),
Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
June 2010, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,
Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
October 2018, Matrix biology : journal of the International Society for Matrix Biology,
Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
August 2002, Matrix biology : journal of the International Society for Matrix Biology,
Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
January 2013, PloS one,
Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
July 2006, Arthritis and rheumatism,
Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
January 2003, Biorheology,
Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
August 2022, International journal of molecular sciences,
Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
August 2012, Arthritis research & therapy,
Masaki Kobayashi, and Keigo Kawabata, and Ayumi Kusaka-Kikushima, and Yoshinori Sugiyama, and Tomotaka Mabuchi, and Susumu Takekoshi, and Muneo Miyasaka, and Akira Ozawa, and Shingo Sakai
June 2012, The Journal of biological chemistry,
Copied contents to your clipboard!